<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fourteen patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were treated with antilymphocyte globulin (ALG) </plain></SENT>
<SENT sid="1" pm="."><plain>Eight were studied with co-culture of patient's lymphocytes with <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow cells </plain></SENT>
<SENT sid="2" pm="."><plain>Suppression of CFU-C was prevented by pretreatment of T lymphocytes with anti-T lymphocyte McAb in four patients and concordance with clinical outcome was observed only in two patients </plain></SENT>
<SENT sid="3" pm="."><plain>Conclusive in vivo therapy result for this correspondence are lacking </plain></SENT>
<SENT sid="4" pm="."><plain>Seven patients received fetal liver cell suspension infusion 24-36 hours after completing ALG therapy and remission were "more complete" in three cases with good response </plain></SENT>
<SENT sid="5" pm="."><plain>Response of treatment in the fourteen patients was as follows: eight had complete or partial responses and the remaining did not respond or died (42.8%) </plain></SENT>
</text></document>